The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.

particularly when safe and effective FDA-approved medicines are available," the company said in a statement. "Yet many entities continue to mass produce unapproved tirzepatide knockoffs that may ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

Opens in a new tab or window SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body ...

Sales of Eli Lilly’s diabetes and weight loss drugs fell far short of expectations in the third quarter, leading the juggernaut company to reduce its annual revenue guidance and triggering speculation ...

However, you’ll need to choose a telehealth company that offers compounded formulations. All of the companies reviewed in this article offer compounded tirzepatide. Any state-licensed, board-certified ...

SAN ANTONIO – Once-weekly tirzepatide (Zepbound) reduced the risk for progression from prediabetes to type 2 diabetes (T2D) ...

Its generic version is tirzepatide, but it is only available ... The cost of membership does not cover a person’s medication. Noom is a company that promotes a holistic approach to weight ...

Novo Nordisk seeks to put a stop to semaglutide compounding, whereas the FDA agrees to allow compounding of tirzepatide, for ...

LLY’s slashed revenue and earnings guidance for 2024 were a surprise, especially given substantial raises to its outlook ...